Stocks Climb, on Track for Fresh Records – The Wall Street Journal
Stocks Climb, on Track for Fresh Records The Wall Street Journal
Global Stocks Inch Up as Inflation Stays in Focus Barron’s
…
Global
Biogen Gains, Vertex Pharmaceuticals Drops, and the Stock Market Keeps Rising
Stocks look set for a higher open as a bipartisan group of senators reached an infrastructure deal.
Vertex defended after setback and Biogen adds another bull at Bernstein; in today’s analyst action
Vertex defended across the board despite the setbackVertex Pharmaceuticals (VRTX) continues to trade lower with a~14.0% lossin…
Canadian Apartment Properties REIT: A REIT For All Market Conditions
Canadian Apartment Properties Real Estate Investment Trust boasts great fundamentals, a strong business model, and demographic…
LifeMD Names Experienced Pharma Executive Alexander Mironov as President
A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare,…
Did UPS Stock Really Warrant A Decline Following Its 2023 Guidance?
The stock price of United Parcel Service has seen a 5.1% drop over the last five trading days. The drop came after the company…
DraftKings’ Founders Say Profitability Depends On Rollout Of States Legalizing Sports Betting
The company’s three cofounders see vast potential for growth as more states legalize sports betting, but the industry is still…
GOLDMAN SACHS: Stocks with surging retail-trading volumes are ripe with money-making opportunities if you know when to get out. Here are 40 popular stocks investors can use to play the meme trade
Summary List PlacementThe retail trading mania that captured the attention of global investors in January has returned in full…
US-based Faire raises $260M at a $7B valuation; reports 300% YoY growth after expanding across key European markets – Silicon Canals
US-based Faire raises $260M at a $7B valuation; reports 300% YoY growth after expanding across key European markets Silicon…
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted CAR T in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
Data presented at the European Hematology Association 2021 Virtual Congress show favorable safety profile and compelling clinical…